Published in Health Policy Plan on December 01, 1998
Water, sanitation, hygiene, and soil-transmitted helminth infection: a systematic review and meta-analysis. PLoS Med (2014) 2.35
Prevalence and factors associated with intestinal parasitic infection among children in an urban slum of Karachi. PLoS One (2008) 1.80
Role of the employment status and education of mothers in the prevalence of intestinal parasitic infections in Mexican rural schoolchildren. BMC Public Health (2006) 1.60
Prevalence and risk factors for soil-transmitted helminth infection in mothers and their infants in Butajira, Ethiopia: a population based study. BMC Public Health (2010) 1.41
Parasitic worms: knowledge, attitudes, and practices in Western Côte d'Ivoire with implications for integrated control. PLoS Negl Trop Dis (2010) 1.19
Prevalence & risk factors for soil transmitted helminth infection among school children in south India. Indian J Med Res (2014) 1.06
Prevalence of intestinal parasites versus knowledge, attitudes, and practices of inhabitants of low-income communities of Campos dos Goytacazes, Rio de Janeiro State, Brazil. Parasitol Res (2010) 0.94
The development of TH2 responses from infancy to 4 years of age and atopic sensitization in areas endemic for helminth infections. Allergy Asthma Clin Immunol (2013) 0.93
Prevalence and risk factors of intestinal helminth infection among rural malay children. J Glob Infect Dis (2012) 0.77
Community awareness of intestinal parasites and the prevalence of infection among community members of rural Abaye Deneba area, Ethiopia. Asian Pac J Trop Biomed (2014) 0.77
Webuye Health and Demographic Surveillance Systems Baseline Survey of Soil-Transmitted Helminths and Intestinal Protozoa among Children up to Five Years. J Trop Med (2013) 0.76
Knowledge, practices and perceptions of geo-helminthes infection among parents of pre-school age children of coastal region, Kenya. PLoS Negl Trop Dis (2017) 0.75
The impact of cooperative social organization on reducing the prevalence of malaria and intestinal parasite infections in awramba, a rural community in South gondar, ethiopia. Interdiscip Perspect Infect Dis (2014) 0.75
Intestinal Infestations in Under-Five Children in Zambia. Int J MCH AIDS (2015) 0.75
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Association between hepatitis E virus and HIV infection in homosexual men. Lancet (1994) 2.49
Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group. Arch Intern Med (1998) 2.38
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood (1999) 2.10
AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology (2000) 2.05
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst (1999) 2.01
Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998. Lazio AIDS Surveillance Collaborative Group. AIDS (1999) 1.92
High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS (1996) 1.92
Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer (1997) 1.73
How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS) J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.57
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study. AIDS (2001) 1.41
Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study. Neurology (1999) 1.38
Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J Infect Dis (1997) 1.29
Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS (2000) 1.23
Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer (1999) 1.20
Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study. Acta Psychiatr Scand (2002) 1.09
HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding. AIDS (1992) 1.04
Chronic constipation in hemiplegic patients. World J Gastroenterol (2007) 1.04
Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol (1992) 1.03
Increasing proportion of late testers among AIDS cases in Italy, 1996-2002. AIDS Care (2005) 1.02
Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis (2000) 1.02
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. J Infect Dis (1999) 1.01
Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment. Italian HIV Seroconversion Study (ISS). J Acquir Immune Defic Syndr (1999) 1.01
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect (2001) 1.00
Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer (1998) 0.99
Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. J Infect Dis (1995) 0.98
Antiretroviral treatment-based cost saving interventions may offset expenses for new patients and earlier treatment start. HIV Med (2013) 0.97
The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count. The Italian Seroconversion Study. Epidemiol Infect (1998) 0.97
Is there a general tendency for CD4 lymphocyte decline to speed up during human immunodeficiency virus infection? Evidence from the Italian Seroconversion Study. J Infect Dis (1997) 0.97
CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study. AIDS (1994) 0.96
An analysis of individual, household, and environmental risk factors for intestinal helminth infection among children in Qena Governorate, Upper Egypt. J Trop Pediatr (1999) 0.96
NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children. Neurology (2009) 0.95
Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study. AIDS (2000) 0.95
Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group. JAMA (1992) 0.93
Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr (2000) 0.93
Suspected transmission of tuberculosis in a maternity ward from a smear-positive nurse: preliminary results of clinical evaluations and testing of neonates potentially exposed, Rome, Italy, 1 January to 28 July 2011. Euro Surveill (2011) 0.93
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART. J Acquir Immune Defic Syndr (2001) 0.92
Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol (1997) 0.90
Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. Am J Epidemiol (1996) 0.90
Syndromic surveillance: sensitivity and positive predictive value of the case definitions. Epidemiol Infect (2008) 0.89
HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. DIANAIDS Collaborative Study Group. Int J Cancer (1997) 0.87
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group. J Acquir Immune Defic Syndr (2000) 0.87
Prevalence of sexual and physical abuse and its relationship with symptom manifestations in patients with chronic organic and functional gastrointestinal disorders. Dig Liver Dis (2003) 0.87
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. AIDS (1995) 0.86
Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS. J Acquir Immune Defic Syndr (1992) 0.85
The influence of hemocoagulative disorders on the outcome of children with head injury. Pediatr Neurosurg (2001) 0.85
Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression. Am J Epidemiol (1997) 0.84
Monitoring HIV trends in injecting drug users: an Italian experience. AIDS (1990) 0.84
Relationship between gastrointestinal and extra-gastrointestinal symptoms and delayed gastric emptying in functional dyspeptic patients. World J Gastroenterol (2005) 0.83
Acquired immunodeficiency without HIV infection: epidemiology and clinical outcome in Italy. The Italian Study Group on non-HIV AIDS. BMJ (1995) 0.83
Is the clinical course of HIV infection changing? Study's censoring strategy may be source of bias. BMJ (1997) 0.83
Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus. Italian HIV Seroconversion Study. Clin Infect Dis (1996) 0.82
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. J Infect Dis (2000) 0.82
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy. Antivir Ther (2001) 0.81
Cytotoxin-associated gene A and vacuolating cytotoxin A in human isolates of Helicobacter pylori and their association with the clinical status of ulcer disease. Eur J Gastroenterol Hepatol (2000) 0.81
HIV-1 disease progression in women: role of the viral phenotype of the HIV-positive steady partner. AIDS (1999) 0.81
Hospital use by HIV patients in Italy: a retrospective longitudinal study. National Study Group on HIV-Related Hospital Use. J Acquir Immune Defic Syndr (1991) 0.81
Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users. J Biol Regul Homeost Agents (1992) 0.80
Does breast-feeding delay progression to AIDS in HIV-infected children? AIDS (1990) 0.80
IgA as a marker of clinical progression among HIV-seropositive intravenous drug users. J Infect (1993) 0.80
Changing disease patterns in focal brain lesion-causing disorders in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.79
Multiple imputation method for estimating incidence of HIV infection. The Multicenter Prospective HIV Study. Int J Epidemiol (1997) 0.79
Use of AIDS surveillance data to describe subepidemic dynamics. Int J Epidemiol (1995) 0.78
[A cross-sectional survey on childhood immunization coverage and reasons of non-compliance in Lazio Region, Italy (2007)]. Ann Ig (2009) 0.78
Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments? J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.78
Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy. Eur J Epidemiol (1998) 0.78
Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 0.78
Inter-rater reliability of a modified Karnofsky Scale of Performance Status for HIV-infected individuals. AIDS Patient Care STDS (1999) 0.77
Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study. AIDS (1997) 0.77
Clinical signs and household characteristics associated with human fascioliasis among rural population in Egypt: a case-control study. Parassitologia (2003) 0.76
Improving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive i.v. drug users. Infection (1997) 0.76
Predictors of survival in children with acquired immunodeficiency syndrome in Italy, 1983 to 1995. AIDS Patient Care STDS (1998) 0.76
HIV/AIDS surveillance in Italy: the potential misinterpretation of time trends. Am J Public Health (1997) 0.75
HIV exposure category and invasive cervical carcinoma in Italy. AIDS (1997) 0.75
Re: Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst (1999) 0.75
Clinical staging system for AIDS patients. Lancet (1995) 0.75
[Prevalence of HIV infection in Italian drug users attending drug treatment centers in the years 1990-92]. Ann Ist Super Sanita (1995) 0.75
Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study. Antivir Ther (1997) 0.75
[Clinical picture of the onset of AIDS in 2911 adults in Italy]. Medicina (Firenze) (1989) 0.75
Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial. J Acquir Immune Defic Syndr (2001) 0.75
[Color echo-doppler in the follow-up of subclavian and axillary phlebothrombosis treated with locoregional thrombolysis]. Minerva Cardioangiol (1998) 0.75
Markov models for HIV disease progression: an unverified assumption. J Acquir Immune Defic Syndr (2000) 0.75
The Italian AIDS 'hot-line': providing information to the people. AIDS Care (1989) 0.75
Antiretroviral combination therapies and AIDS-defining cancers. J Acquir Immune Defic Syndr (2000) 0.75
[Trends in the prevalence and geographic distribution of HIV infection among Italian drug addicts in treatment provided by public assistance services during 1990-1994]. Ann Ig (1997) 0.75
Age speeds onset of AIDS following HIV infection. Nurs Times (1997) 0.75
Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. Italian Seroconversion Study group. Eur J Epidemiol (1999) 0.75
Monitoring the trend of the transmission rate of vertically acquired HIV infection: a simple method applied to Italian data. J Biol Regul Homeost Agents (2001) 0.75
Longitudinal analysis of the 90K glycoprotein in the Italian HIV-seroconversion study: temporal trend and predictability of the maturity of HIV infection. J Biol Regul Homeost Agents (2004) 0.75
Risk behaviour and HTLV-1 seropositivity in injecting drug users. Br J Addict (1990) 0.75
Evaluation of symptoms suggestive of HIV acute disease among injecting drug users. J Infect (1995) 0.75